Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Wei Zhu, Guolong Wu et al.|Journal of Medicinal Chemistry|2017Cited by 59